Connors Investor Services Inc. Acquires 3,671 Shares of Simulations Plus, Inc. $SLP

Connors Investor Services Inc. boosted its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 37.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,500 shares of the technology company’s stock after purchasing an additional 3,671 shares during the period. Connors Investor Services Inc. owned about 0.07% of Simulations Plus worth $236,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SLP. US Bancorp DE lifted its stake in Simulations Plus by 15.6% during the first quarter. US Bancorp DE now owns 6,576 shares of the technology company’s stock worth $161,000 after purchasing an additional 889 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Simulations Plus during the first quarter worth about $210,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Simulations Plus by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock worth $233,000 after purchasing an additional 390 shares during the period. Savvy Advisors Inc. bought a new position in Simulations Plus during the first quarter worth about $249,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Simulations Plus during the first quarter worth about $255,000. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Price Performance

Shares of Simulations Plus stock opened at $17.62 on Thursday. The firm has a market cap of $354.69 million, a P/E ratio of -5.59 and a beta of 0.99. The firm has a 50 day simple moving average of $14.96 and a 200 day simple moving average of $20.63. Simulations Plus, Inc. has a fifty-two week low of $12.39 and a fifty-two week high of $37.67.

Wall Street Analyst Weigh In

SLP has been the subject of a number of research analyst reports. KeyCorp cut shares of Simulations Plus from an “overweight” rating to a “sector weight” rating in a research note on Tuesday, July 15th. BTIG Research cut their target price on shares of Simulations Plus from $41.00 to $25.00 and set a “buy” rating for the company in a research note on Monday, July 7th. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research note on Tuesday, July 15th. TD Cowen initiated coverage on shares of Simulations Plus in a research note on Tuesday, September 30th. They issued a “hold” rating and a $16.00 target price for the company. Finally, Zacks Research upgraded shares of Simulations Plus to a “hold” rating in a research note on Tuesday, August 12th. Four equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $24.40.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.